Lung cancer is one of the most common, most dangerous, and most frequently talked about forms of cancer in the world. Of all ...

RiboD-PETRI, a cost-effective, equipment-free plate-based scRNA-seq technique that integrates a unique bacterial rRNA depletion protocol, significantly enhancing mRNA detection rate and revealing ...

Multicancer early detection testing results in extended life-years and reduced cancer treatment costs through earlier diagnosis, leading to a cost-effective option in cancer screening.

The global cancer biopsy market is set to experience robust growth, with a market size of USD 25.5 billion in 2023, according ...

Sabari, MD, which focused on the approval of amivantamab plus lazertinib in the first line, he looks ahead to potential uses ...

Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), in partnership with the American Association for Cancer Research (AACR), is hosting the 47th ...

The FDA has granted accelerated approval to zenocutuzumab, a new drug for adults with advanced non-small-cell lung cancer ...

By inferring proliferation rates from single-cell genomics, SPRINTER enhances understanding of tumor evolution and identifies ...

A new laboratory study provides evidence about how advanced age can be protective against cancer — with implications for ...

The first computer algorithm capable of identifying which tumor cells are driving aggressive cancer growth has been developed ...

We evaluate the actionability of SD in a highly heterogeneous and rare demographic: adolescents and young adults (AYAs) with cancer. A population-based cross-sectional cohort study of 3,735 AYAs was ...